[Inotropic agents in advanced and refractory heart failure].
Mangiavacchi
Maurizio
M
Gronda
Edoardo
E
D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006333:Heart Failure / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D011724:Pyridazines / Q000627:therapeutic use; D000077464:Simendan; D017211:Treatment Failure; D016896:Treatment Outcome
D002316:Cardiotonic Agents; D006835:Hydrazones; D010726:Phosphodiesterase Inhibitors; D011724:Pyridazines; D000077464:Simendan; D004280:Dobutamine; D004298:Dopamine
Gli inotropi nello scompenso cardiaco avanzato e refrattario.